Prepare Yourself for Liftoff: Amneal Pharmaceuticals Inc (AMRX)

With 0.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.72 shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $5.57 whereas the lowest price it dropped to was $5.41. The 52-week range on AMRX shows that it touched its highest point at $6.30 and its lowest point at $1.24 during that stretch. It currently has a 1-year price target of $6.62. Beta for the stock currently stands at 1.33.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMRX was up-trending over the past week, with a rise of 0.91%, but this was up by 1.09% over a month. Three-month performance surged to 37.19% while six-month performance rose 31.68%. The stock gained 106.30% in the past year, while it has lost -8.24% so far this year. A look at the trailing 12-month EPS for AMRX yields 0.06 with Next year EPS estimates of 0.60. For the next quarter, that number is 0.09. This implies an EPS growth rate of -12.94% for this year and 0.68% for next year.

Float and Shares Shorts:

At present, 151.49 million AMRX shares are outstanding with a float of 110.04 million shares on hand for trading. On Jan 31, 2024, short shares totaled 2.54 million, which was 0.83% higher than short shares on Dec 29, 2023. In addition to Mr. Chirag K. Patel as the firm’s Co-Founder, Co-CEO, President & Director, Mr. Chintu Patel R.Ph. serves as its Co-Founder, Co-CEO & Director.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMRX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMRX analysts setting a high price target of $8.00 and a low target of $5.50, the average target price over the next 12 months is $6.63. Based on these targets, AMRX could surge 43.63% to reach the target high and fall by -1.26% to reach the target low. Reaching the average price target will result in a growth of 19.03% from current levels.

Summary of Insider Activity:

Insiders traded AMRX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 23 while that of sell transactions has risen to 11 over the past year. The total number of shares bought during that period was 54,748,347 while 169,121 shares were sold.